Healthcare & Life Sciences
miRagen Therapeutics
United Statesmiragen.com
miRagen Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About miRagen Therapeutics
miRagen Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
miRagen Therapeutics develops oligonucleotide-based therapies that regulate microRNA activity to treat cardiovascular and fibrotic diseases.
Explore miRagen Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.